Oxford Nanopore Technologies (LON:ONT) Earns Overweight Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their overweight rating on shares of Oxford Nanopore Technologies (LON:ONT) in a report published on Thursday morning, Marketbeat.com reports.

ONT has been the subject of several other research reports. Citigroup reiterated a buy rating and issued a GBX 210 ($2.67) price objective on shares of Oxford Nanopore Technologies in a research report on Friday, April 12th. Berenberg Bank reiterated a buy rating and issued a GBX 350 ($4.45) price objective on shares of Oxford Nanopore Technologies in a research report on Wednesday, April 17th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of Buy and a consensus target price of GBX 303.75 ($3.86).

Oxford Nanopore Technologies Price Performance

Shares of LON ONT opened at GBX 110.30 ($1.40) on Thursday. The stock has a fifty day moving average price of GBX 111.70 and a 200 day moving average price of GBX 150.42. The company has a market cap of £951.44 million, a PE ratio of -580.53 and a beta of 0.64. The company has a debt-to-equity ratio of 6.47, a current ratio of 5.01 and a quick ratio of 6.01. Oxford Nanopore Technologies has a 1-year low of GBX 91.24 ($1.16) and a 1-year high of GBX 279 ($3.55).

Insider Activity at Oxford Nanopore Technologies

In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera purchased 39,196 shares of the firm’s stock in a transaction on Wednesday, March 6th. The shares were purchased at an average cost of GBX 127 ($1.61) per share, with a total value of £49,778.92 ($63,267.56). In other news, insider Kate Priestman acquired 23,564 shares of Oxford Nanopore Technologies stock in a transaction dated Tuesday, April 30th. The shares were acquired at an average cost of GBX 106 ($1.35) per share, with a total value of £24,977.84 ($31,746.11). Also, insider Gurdial (Gordon) Sanghera acquired 39,196 shares of Oxford Nanopore Technologies stock in a transaction dated Wednesday, March 6th. The stock was purchased at an average cost of GBX 127 ($1.61) per share, for a total transaction of £49,778.92 ($63,267.56). Insiders have purchased a total of 63,021 shares of company stock valued at $7,505,560 over the last quarter. Insiders own 29.98% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.